Tersera Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TERSERA, and what generic alternatives to TERSERA drugs are available?
TERSERA has seven approved drugs.
There are seventeen US patents protecting TERSERA drugs.
There are two hundred and twenty-one patent family members on TERSERA drugs in thirty-eight countries and forty-one supplementary protection certificates in eighteen countries.
Summary for Tersera
| International Patents: | 221 |
| US Patents: | 17 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 7 |
Drugs and US Patents for Tersera
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | RX | Yes | Yes | 8,765,680 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | XERMELO | telotristat etiprate | TABLET;ORAL | 208794-001 | Feb 28, 2017 | RX | Yes | Yes | 7,709,493 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Tersera | QMIIZ ODT | meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210-002 | Oct 19, 2018 | DISCN | Yes | No | 8,545,879 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Tersera | VARUBI | rolapitant hydrochloride | TABLET;ORAL | 206500-001 | Sep 1, 2015 | RX | Yes | Yes | 8,470,842 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-001 | Dec 28, 2004 | RX | Yes | Yes | 9,707,270 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-004 | Dec 28, 2004 | RX | Yes | Yes | 8,653,033 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | XERMELO | telotristat etiprate | TABLET;ORAL | 208794-001 | Feb 28, 2017 | RX | Yes | Yes | 7,553,840 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Tersera
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-001 | Dec 28, 2004 | 5,795,864 | ⤷ Try a Trial |
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | 5,364,842 | ⤷ Try a Trial |
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | 5,795,864 | ⤷ Try a Trial |
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-004 | Dec 28, 2004 | 5,859,186 | ⤷ Try a Trial |
| Tersera | VARUBI | rolapitant hydrochloride | EMULSION;INTRAVENOUS | 208399-001 | Oct 25, 2017 | 8,796,299 | ⤷ Try a Trial |
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 020578-001 | Jan 11, 1996 | 4,100,274 | ⤷ Try a Trial |
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | 7,220,247 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Tersera Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I412365 | ⤷ Try a Trial |
| China | 1606545 | ⤷ Try a Trial |
| China | 103751186 | ⤷ Try a Trial |
| Poland | 370841 | ⤷ Try a Trial |
| Norway | 2021010 | ⤷ Try a Trial |
| Canada | 2681465 | ⤷ Try a Trial |
| European Patent Office | 3143996 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tersera Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2091940 | 300929 | Netherlands | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT |
| 2091940 | C02091940/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66374 28.03.2018 |
| 2091940 | 2018/011 | Ireland | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT OR A PHARMACEUTICALLY ACCEPTABLE ESTER, OR A SALT THEROF, IN PARTICULAR TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL.; REGISTRATION NO/DATE: EU/1/17/1224 20170918 |
| 2091940 | C201830016 | Spain | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT, O ESTER FARMACEUTICAMENTE ACEPTABLE, O UNA SALA DEL MISMO, EN PARTICULAR TELOTRISTAT DE ESTILO, MAS PARTICULARMENTE LA SAL HIPURATO DE TELOTRISTAT DE ETILO; NATIONAL AUTHORISATION NUMBER: EU/1/17/1224; DATE OF AUTHORISATION: 20170918; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1224; DATE OF FIRST AUTHORISATION IN EEA: 20170918 |
| 1463716 | 318 50015-2017 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/17/1180 20170424 |
| 2091940 | 1890014-2 | Sweden | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT OR A PHARMACEUTICALLY ACCEPTABLE ESTER, OR A SALT THEREOF, IN PARTICULARLY TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL; REG. NO/DATE: EU/1/17/1224 20170920 |
| 2091940 | 11/2018 | Austria | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARER ESTER, ODER EIN SALZ DAVON, INSBESONDERE TELOTRISTATETHYL, INSBESONDERE DAS HIPPURATSALZ VON TELOTRISTATETHYL; REGISTRATION NO/DATE: EU/1/17/1224 (MITTEILUNG) 20170920 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
